Literature DB >> 33780951

Applications of the Chick Chorioallantoic Membrane as an Alternative Model for Cancer Studies.

Pei-Yu Chu1, Angele Pei-Fern Koh2, Jane Antony3, Ruby Yun-Ju Huang4,5.   

Abstract

A variety of in vivo experimental models have been established for the studies of human cancer using both cancer cell lines and patient-derived xenografts (PDXs). In order to meet the aspiration of precision medicine, the in vivomurine models have been widely adopted. However, common constraints such as high cost, long duration of experiments, and low engraftment efficiency remained to be resolved. The chick embryo chorioallantoic membrane (CAM) is an alternative model to overcome some of these limitations. Here, we provide an overview of the applications of the chick CAM model in the study of oncology. The CAM model has shown significant retention of tumor heterogeneity alongside increased xenograft take rates in several PDX studies. Various imaging techniques and data analysis have been applied to study tumor metastasis, angiogenesis, and therapeutic response to novel agents. Lastly, to practically illustrate the feasibility of utilizing the CAM model, we summarize the general protocol used in a case study utilizing an ovarian cancer PDX.
© 2021 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cancer; Chorioallantoic membrane; Patient-derived xenograft; Tumor

Mesh:

Year:  2021        PMID: 33780951      PMCID: PMC9153341          DOI: 10.1159/000513039

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.208


  136 in total

1.  A quantitative analysis of rate-limiting steps in the metastatic cascade using human-specific real-time polymerase chain reaction.

Authors:  Andries Zijlstra; Rebecca Mellor; Giano Panzarella; Ronald T Aimes; John D Hooper; Natalia D Marchenko; James P Quigley
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  Growth of transplantable human tumors in the chick embryo and hatched chick.

Authors:  C P DAGG; D A KARNOFSKY; J RODDY
Journal:  Cancer Res       Date:  1956-08       Impact factor: 12.701

3.  Unexpected effect of matrix metalloproteinase down-regulation on vascular intravasation and metastasis of human fibrosarcoma cells selected in vivo for high rates of dissemination.

Authors:  Elena I Deryugina; Andries Zijlstra; Juneth J Partridge; Tatyana A Kupriyanova; Mark A Madsen; Thales Papagiannakopoulos; James P Quigley
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

4.  Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes.

Authors:  Yoko S DeRose; Guoying Wang; Yi-Chun Lin; Philip S Bernard; Saundra S Buys; Mark T W Ebbert; Rachel Factor; Cindy Matsen; Brett A Milash; Edward Nelson; Leigh Neumayer; R Lor Randall; Inge J Stijleman; Bryan E Welm; Alana L Welm
Journal:  Nat Med       Date:  2011-10-23       Impact factor: 53.440

5.  Effects of Monascus-fermented rice extract on malignant cell-associated neovascularization and intravasation determined using the chicken embryo chorioallantoic membrane model.

Authors:  Bing-Ying Ho; Yao-Ming Wu; Ya-Wen Hsu; Li-Chuan Hsu; Yao-Haur Kuo; King-Jen Chang; Tzu-Ming Pan
Journal:  Integr Cancer Ther       Date:  2010-03-31       Impact factor: 3.279

6.  Morphometric measurements of chorioallantoic membrane vascularity: effects of hypoxia and hyperoxia.

Authors:  D M Strick; R L Waycaster; J P Montani; W J Gay; T H Adair
Journal:  Am J Physiol       Date:  1991-04

7.  The tumour suppressor OPCML promotes AXL inactivation by the phosphatase PTPRG in ovarian cancer.

Authors:  Jane Antony; Elisa Zanini; Zoe Kelly; Tuan Zea Tan; Evdoxia Karali; Mohammad Alomary; Youngrock Jung; Katherine Nixon; Paula Cunnea; Christina Fotopoulou; Andrew Paterson; Sushmita Roy-Nawathe; Gordon B Mills; Ruby Yun-Ju Huang; Jean Paul Thiery; Hani Gabra; Chiara Recchi
Journal:  EMBO Rep       Date:  2018-06-15       Impact factor: 8.807

8.  Overexpression of malignancy-associated laminins and laminin receptors by angiotropic human melanoma cells in a chick chorioallantoic membrane model.

Authors:  Claire Lugassy; Jorge E Torres-Muñoz; Hynda K Kleinman; Ghanem Ghanem; Stephen Vernon; Raymond L Barnhill
Journal:  J Cutan Pathol       Date:  2009-12       Impact factor: 1.587

9.  The avian chorioallantoic membrane as an alternative tool to study medullary thyroid cancer.

Authors:  Nassim Ghaffari-Tabrizi-Wizsy; Christina Angelika Passegger; Laura Nebel; Fabian Krismer; Gudrun Herzer-Schneidhofer; Gert Schwach; Roswitha Pfragner
Journal:  Endocr Connect       Date:  2019-05-01       Impact factor: 3.335

10.  In vivo Wnt pathway inhibition of human squamous cell carcinoma growth and metastasis in the chick chorioallantoic model.

Authors:  Shannon F Rudy; J Chad Brenner; Jennifer L Harris; Jun Liu; Jianwei Che; Megan V Scott; John Henry Owen; Christine M Komarck; Martin P Graham; Emily L Bellile; Carol R Bradford; Mark E P Prince; Thomas E Carey
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-04-26
View more
  10 in total

1.  Transient and Efficient Vascular Permeability Window for Adjuvant Drug Delivery Triggered by Microbeam Radiation.

Authors:  Sarah Sabatasso; Cristian Fernandez-Palomo; Ruslan Hlushchuk; Jennifer Fazzari; Stefan Tschanz; Paolo Pellicioli; Michael Krisch; Jean A Laissue; Valentin Djonov
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

Review 2.  Microvascular Experimentation in the Chick Chorioallantoic Membrane as a Model for Screening Angiogenic Agents including from Gene-Modified Cells.

Authors:  Donna C Kennedy; Barbara Coen; Antony M Wheatley; Karl J A McCullagh
Journal:  Int J Mol Sci       Date:  2021-12-31       Impact factor: 5.923

Review 3.  The Chicken Embryo Model: A Novel and Relevant Model for Immune-Based Studies.

Authors:  Paul Garcia; Yan Wang; Jean Viallet; Zuzana Macek Jilkova
Journal:  Front Immunol       Date:  2021-11-19       Impact factor: 7.561

4.  Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach.

Authors:  Yee Kit Tai; Karen Ka Wing Chan; Charlene Hui Hua Fong; Sharanya Ramanan; Jasmine Lye Yee Yap; Jocelyn Naixin Yin; Yun Sheng Yip; Wei Ren Tan; Angele Pei Fern Koh; Nguan Soon Tan; Ching Wan Chan; Ruby Yun Ju Huang; Jing Ze Li; Jürg Fröhlich; Alfredo Franco-Obregón
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 5.738

5.  A Face-To-Face Comparison of Tumor Chicken Chorioallantoic Membrane (TCAM) In Ovo with Murine Models for Early Evaluation of Cancer Therapy and Early Drug Toxicity.

Authors:  Tristan Rupp; Christophe Legrand; Marion Hunault; Laurie Genest; David Babin; Guillaume Froget; Vincent Castagné
Journal:  Cancers (Basel)       Date:  2022-07-21       Impact factor: 6.575

Review 6.  Functional Drug Screening in the Era of Precision Medicine.

Authors:  Giulia C Napoli; William D Figg; Cindy H Chau
Journal:  Front Med (Lausanne)       Date:  2022-07-08

Review 7.  Replacement in angiogenesis research: Studying mechanisms of blood vessel development by animal-free in vitro, in vivo and in silico approaches.

Authors:  Matthias W Laschke; Yuan Gu; Michael D Menger
Journal:  Front Physiol       Date:  2022-08-17       Impact factor: 4.755

8.  Embryonated Chicken Tumor Xenografts Derived from Circulating Tumor Cells as a Relevant Model to Study Metastatic Dissemination: A Proof of Concept.

Authors:  Xavier Rousset; Denis Maillet; Emmanuel Grolleau; David Barthelemy; Sara Calattini; Marie Brevet; Julie Balandier; Margaux Raffin; Florence Geiguer; Jessica Garcia; Myriam Decaussin-Petrucci; Julien Peron; Nazim Benzerdjeb; Sébastien Couraud; Jean Viallet; Léa Payen
Journal:  Cancers (Basel)       Date:  2022-08-23       Impact factor: 6.575

Review 9.  In ovo model in cancer research and tumor immunology.

Authors:  Lea Miebach; Julia Berner; Sander Bekeschus
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

10.  Chick Chorioallantoic Membrane (CAM) Assays as a Model of Patient-Derived Xenografts from Circulating Cancer Stem Cells (cCSCs) in Breast Cancer Patients.

Authors:  Monika Pizon; Dorothea Schott; Ulrich Pachmann; Rainer Schobert; Marek Pizon; Marta Wozniak; Rafal Bobinski; Katharina Pachmann
Journal:  Cancers (Basel)       Date:  2022-03-14       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.